FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Concertgoer dies after apparent fall from upper level at Madison Square Garden

‘The Era of Deportations Has Begun’: European Parliament Passes Toughest Immigration Policy in Decades

Multiple hikers dead amid scorching Grand Canyon temperatures

Mark Levin blasts Trump administration over Israel: ‘Stop trashing, smearing, bullying’ ally

Trump’s Iran gamble divides GOP hawks and ‘America First’ conservatives over what victory looks like

College sports sees pivotal moment as Senate looks to move legislation on NIL, transfers across goal line

New Report Says Major School System Hid Admissions Data Defying Supreme Court

Perverted: Meal Kit Company Runs Gross Pride Month Ad, Offering Recipes to Aid Vile Sex Act

Trump’s DOJ Just Did What Decades of Speeches Never Could

Elon Musk Gets Dealt Blow By Biden-Appointed Judge Days After Becoming Trillionaire

FAA investigates after incoming plane executes go-around due to aircraft leaving from intersecting runway

God’s Way Is Best – Marriage Found to Have Huge Benefits When It Comes to Cancer, Heart Health, Mental Health

Responders put out explosive blaze at fireworks stand in Oklahoma

Obama Center visitors say project symbolic of ‘Black excellence,’ claim scandal-free legacy while Trump ripped

Trump administration probe could upend widely used transgender youth treatment guidelines

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”